| Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM L Fontana, ME Fiori, S Albini, L Cifaldi, S Giovinazzi, M Forloni, R Boldrini, ... PloS one 3 (5), e2236, 2008 | 468 | 2008 |
| Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance ME Fiori, S Di Franco, L Villanova, P Bianca, G Stassi, R De Maria Molecular cancer 18, 1-16, 2019 | 453 | 2019 |
| miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and-2 E Kronski, ME Fiori, O Barbieri, S Astigiano, V Mirisola, PH Killian, ... Molecular oncology 8 (3), 581-595, 2014 | 199 | 2014 |
| The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells P Laneve, L Di Marcotullio, U Gioia, ME Fiori, E Ferretti, A Gulino, ... Proceedings of the National Academy of Sciences 104 (19), 7957-7962, 2007 | 188 | 2007 |
| PTEN tumor-suppressor: the dam of stemness in cancer F Luongo, F Colonna, F Calapà, S Vitale, ME Fiori, R De Maria Cancers 11 (8), 1076, 2019 | 139 | 2019 |
| Integrin α7 is a functional marker and potential therapeutic target in glioblastoma TL Haas, MR Sciuto, L Brunetto, C Valvo, M Signore, ME Fiori, ... Cell stem cell 21 (1), 35-50. e9, 2017 | 112 | 2017 |
| Purification, cloning, and characterization of XendoU, a novel endoribonuclease involved in processing of intron-encoded small nucleolar RNAs in Xenopus laevis P Laneve, F Altieri, ME Fiori, A Scaloni, I Bozzoni, E Caffarelli Journal of Biological Chemistry 278 (15), 13026-13032, 2003 | 111 | 2003 |
| Antitumor effect of miR-197 targeting in p53 wild-type lung cancer ME Fiori, C Barbini, TL Haas, N Marroncelli, M Patrizii, M Biffoni, ... Cell Death & Differentiation 21 (5), 774-782, 2014 | 100 | 2014 |
| Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex M Gabbianelli, U Testa, O Morsilli, E Pelosi, E Saulle, E Petrucci, ... Haematologica 95 (8), 1253, 2010 | 58 | 2010 |
| PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells LR Mangiapane, A Nicotra, A Turdo, M Gaggianesi, P Bianca, S Di Franco, ... Gut 71 (1), 119-128, 2022 | 55 | 2022 |
| Cancer stem cells: at the forefront of personalized medicine and immunotherapy ME Fiori, L Villanova, R De Maria Current Opinion in Pharmacology 35, 1-11, 2017 | 50 | 2017 |
| Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery S Di Franco, P Bianca, DS Sardina, A Turdo, M Gaggianesi, V Veschi, ... Nature communications 12 (1), 5006, 2021 | 47 | 2021 |
| CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin S Di Franco, B Parrino, M Gaggianesi, VD Pantina, P Bianca, A Nicotra, ... Iscience 24 (6), 2021 | 33 | 2021 |
| Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells A Po, A Citarella, G Catanzaro, ZM Besharat, S Trocchianesi, F Gianno, ... Scientific Reports 10 (1), 13988, 2020 | 32 | 2020 |
| Micro-economics of apoptosis in cancer: ncRNAs modulation of BCL-2 family members L Villanova, S Careccia, R De Maria, ME Fiori International journal of molecular sciences 19 (4), 958, 2018 | 29 | 2018 |
| miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA/BBC3 and BTG2 ME Fiori, L Villanova, C Barbini, ML De Angelis, R De Maria Cell death & disease 9 (2), 49, 2018 | 29 | 2018 |
| Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant V Veschi, LR Mangiapane, A Nicotra, S Di Franco, E Scavo, T Apuzzo, ... Oncogene 39 (5), 987-1003, 2020 | 25 | 2020 |
| Nobiletin and xanthohumol sensitize colorectal cancer stem cells to standard chemotherapy A Turdo, A Glaviano, G Pepe, F Calapà, S Raimondo, ME Fiori, ... Cancers 13 (16), 3927, 2021 | 24 | 2021 |
| CD147 promotes cell small extracellular vesicles release during colon cancer stem cells differentiation and triggers cellular changes in recipient cells D Lucchetti, F Colella, L Perelli, C Ricciardi-Tenore, F Calapà, ME Fiori, ... Cancers 12 (2), 260, 2020 | 16 | 2020 |
| Stem-like and highly invasive prostate cancer cells expressing CD44v8-10 marker originate from CD44-negative cells C Di Stefano, P Grazioli, RA Fontanella, P De Cesaris, A D'Amore, ... Oncotarget 9 (56), 30905, 2018 | 15 | 2018 |
